Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,408.40
+6.80 (0.49%)
At close: Dec 5, 2025
Concord Biotech Revenue
Concord Biotech had revenue of 2.47B INR in the quarter ending September 30, 2025, a decrease of -20.35%. This brings the company's revenue in the last twelve months to 11.25B, up 3.63% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.
Revenue (ttm)
11.25B
Revenue Growth
+3.63%
P/S Ratio
13.10
Revenue / Employee
7.16M
Employees
1,571
Market Cap
147.34B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Divi's Laboratories | 100.29B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Zydus Lifesciences | 244.94B |
| Mankind Pharma | 135.46B |
| Aurobindo Pharma | 325.14B |
| Alkem Laboratories | 138.90B |